|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM and Bray F: Chapter 2: The
burden of HPV-related cancers. Vaccine. 24:(Suppl 3). S11–S25.
2006. View Article : Google Scholar
|
|
3
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dyson N, Howley PM, Münger K and Harlow E:
The human papilloma virus-16 E7 oncoprotein is able to bind to the
retinoblastoma gene product. Science. 243:934–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosenberg SA, Yang JC and Restifo NP:
Cancer immunotherapy: Moving beyond current vaccines. Nat Med.
10:909–915. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dudley ME and Rosenberg SA:
Adoptive-cell-transfer therapy for the treatment of patients with
cancer. Nat Rev Cancer. 3:666–675. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Postow MA, Callahan MK and Wolchok JD:
Immune checkpoint blockade in cancer therapy. J Clin Oncol.
33:1974–1982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Selenko-Gebauer N, Majdic O, Szekeres A,
Höfler G, Guthann E, Korthäuer U, Zlabinger G, Steinberger P, Pickl
WF, Stockinger H, et al: B7-H1 (programmed death-1 ligand) on
dendritic cells is involved in the induction and maintenance of T
cell anergy. J Immunol. 170:3637–3644. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong H, Strome SE, Salomao DR, Tamura H,
Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al:
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential
mechanism of immune evasion. Nat Med. 8:793–800. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zang X and Allison JP: The B7 family and
cancer therapy: Costimulation and coinhibition. Clin Cancer Res.
13:5271–5279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hino R, Kabashima K, Kato Y, Yaqi H,
Nakamura M, Honjo T, Okazaki T and Tokura Y: Tumor cell expression
of programmed cell death-1 Ligand 1 Is a prognostic factor for
malignant melanoma. Cancer. 116:1757–1766. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tavassoli FA and Devilee P: World Health
Organization classification of tumours. Pathology and Genetics of
the breast an female genital organs Lyon: IARC Press; 2003
|
|
13
|
Dong H, Strome SE, Salomao DR, Tamura H,
Hirano F, Files DB, Roche PC, Lu J, Zhu G, Tamada K, et al:
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential
mechanism of immune evasion. Nat Med. 8:793–800. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muñoz N: Human papillomavirus and cancer:
The epidemiological evidence. J Clin Virol. 19:1–5. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Isaacson Wechsler E, Wang Q, Roberts I,
Pagliarulo E, Jackson D, Untersperger C, Coleman N, Griffin H and
Doorbar J: Reconstruction of human papillomavirus type 16-mediated
early-stage neoplasia implicates E6/E7 deregulation and the loss of
contact inhibition in neoplastic progression. J Virol.
86:6358–6364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Xue Y, Poidinger M, Lim T, Chew
SH, Pang CL, Abastado JP and Thierry F: Mapping of HPV transcripts
in four human cervical lesions using RNAseq suggests quantitative
rearrangements during carcinogenic progression. Virology.
462-463:14–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bahrami AA, Ghaeni A, Tabarraei A,
Sajadian A, Gorji A and Soleimanjahi H: DNA vaccine encoding HPV-16
E7 with mutation in L-Y-C-E pRb-binding motif induces potent
anti-tumor responses in mice. J Virol Methods. 206:12–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang YE and Laimins LA: Microarray
analysis identifies interferon-inducible genes and Stat-1 as major
transcriptional targets of human papillomavirus type 31. J Virol.
74:4174–4182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nees M, Geoghegan JM, Hyman T, Frank S,
Miller L and Woodworth CD: Papillomavirus type 16 oncogenes
downregulate expression of interferon-responsive genes and
upregulate proliferation-associated and NF-kappaB-responsive genes
in cervical keratinocytes. J Virol. 75:4283–4296. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stanley MA: Immune responses to human
papilloma viruses. Indian J Med Res. 130:266–276. 2009.PubMed/NCBI
|
|
21
|
Bontkes HJ, de Gruijl TD, Walboomers JM,
van den Muysenberg AJ, Gunther AW, Scheper RJ, Meijer CJ and Kummer
JA: Assessment of cytotoxic T-lymphocyte phenotype using the
specific markers granzyme B and TIA-1 in cervical neoplastic
lesions. Br J Cancer. 76:1353–1360. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Flies DB, Sandler BJ, Sznol M and Chen L:
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy. Yale J
Biol Med. 84:409–421. 2011.PubMed/NCBI
|
|
23
|
Keir ME, Liang SC, Guleria I, Latchman YE,
Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH and Sharpe
AH: Tissue expression of PD-L1 mediates peripheral T cell
tolerance. J Exp Med. 203:883–895. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fife BT and Pauken KE: The role of the
PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad
Sci. 1217:45–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lyford-Pike S, Peng S, Young GD, Taube JM,
Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, et
al: Evidence for a role the PD-1: PD-L1 pathway in immune
resistance of HPV-associated head and neck squamous cell carcinoma.
Cancer Res. 73:1733–1741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ukpo OC, Thorstad WL and Lewis JS Jr:
B7-H1 expression model for immune evasion in human
papillomavirus-related oropharyngeal squamous cell carcinoma. Head
Neck Pathol. 7:113–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barber DL, Wherry EJ, Masopust D, Zhu B,
Allison JP, Sharpe AH, Freeman GJ and Ahmed R: Restoring function
in exhausted CD8 T cells during chronic viral infection. Nature.
439:682–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Badoual C, Hans S, Merillon N, Van Ryswick
C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A,
Besnier N, et al: PD-1 expression tumor-infiltrating T cells are a
favorable prognostic biomarker in HPV-associated head and neck
cancer. Cancer Res. 73:128–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
